Is this your company? Get featured or correct your listing →
Recent changes
- Aug 26, 2026Aug 26, 2026Small-Cap S-1 Bundle: Dare Bioscience, RZ Wellness Pulse story
- Aug 26, 2026Aug 26, 2026Dare Bioscience Files S-1 After $5.3M Stock Offering Pulse story
- Aug 17, 2026Aug 17, 2026Raised $12.4M SEC EDGAR Form D
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Aug 17, 2026 | funding round | $12.4M | — | SEC EDGAR Form D |
Latest Pulse
- Aug 28, 2026This Week in S-1s: Eight Filings, Zero UnicornsEight S-1 and S-1/A filings hit EDGAR between Aug. 26 and Aug. 27 -- a blank-check shell, a Reg A graduate, a convenience-store operator and a biotech among them, with no venture-scale technology company in the group.→
- Aug 27, 2026Why This Week's IPO Pipeline Is All Micro-CapsThis week's SEC filing wave is dominated by small, often distressed public companies doing dilutive registrations rather than marquee venture-backed IPOs -- a reminder the S-1 pipeline and real IPO news are different datasets.→
- Aug 26, 2026Dare Bioscience Files S-1 After $5.3M Stock OfferingWomen's health biopharma Dare Bioscience filed a new S-1 tied to a $5.3 million registered direct offering that closed in August, as the sub-$1 stock works to fund Phase 3 trials for its hormone-free contraceptive Ovaprene.→
- Aug 26, 2026Small-Cap S-1 Bundle: Dare Bioscience, RZ WellnessDare Bioscience registered resale shares tied to an August warrant placement, while RZ Wellness amended its S-1 to sell 5.5 million shares at 3 cents apiece for a $165,000 OTCQB offering -- among the smallest public raises on record.→
Coverage Timeline
newest firstAll Coverage
IPO$5.3M raise
Dare Bioscience Files S-1 After $5.3M Stock Offering
Women's health biopharma Dare Bioscience filed a new S-1 tied to a $5.3 million registered direct offering that closed in August, as the sub-$1 stock works to fund Phase 3 trials for its hormone-free contraceptive Ovaprene.
DEEP DIVE
Small-Cap S-1 Bundle: Dare Bioscience, RZ Wellness
IPO
Small-Cap S-1 Bundle: Dare Bioscience, RZ Wellness
Dare Bioscience registered resale shares tied to an August warrant placement, while RZ Wellness amended its S-1 to sell 5.5 million shares at 3 cents apiece for a $165,000 OTCQB offering -- among the smallest public raises on record.
BY THE NUMBERS
Related Companies
Dare Bioscience FAQ
Is Dare Bioscience publicly traded?
Yes. Dare Bioscience trades.
Sources & methodologyshow
Where these figures come from
- SEC EDGAR Form Dprimary source1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.